logo
Volume 11, Issue 6 (2-2014)                   RBS 2014, 11(6): 510-521 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

برکتين م, گرجاني خ, احمد زاده غ, مرآثي م. Adherence of treatment of schizophrenia to the published treatment guidelines in university hospital. RBS 2014; 11 (6) :510-521
URL: http://rbs.mui.ac.ir/article-1-343-en.html
1- دانشجوي دکتراي، پزشکي عمومي، دانشکده پزشکي ، دانشگاه علوم پزشکي اصفهان، اصفهان، ايران
2- دانشيار، مركز تحقيقات علوم رفتاري، گروه روان‌پزشكي، دانشكده پزشكي، دانشگاه علوم پزشكي اصفهان، اصفهان، ايران
3- دانشيار، مركز تحقيقات علوم رفتاري،گروه اپيدميولوژي و آمار زيستي،دانشکده بهداشت، دانشگاه علوم پزشکي اصفهان ،اصفهان،ايران
Abstract:   (1626 Views)
Abstract Aim and Background: Applying evidence-based treatment guidelines to improve the quality of care for patients with schizophrenia has been increased worldwide. In this study, we evaluated the adherence of clinicians to the guideline for patients with schizophrenia who were admitted to a university hospital in their first episode of disease. Methods and Materials: In a descriptive study, treatments of all patients who were admitted to Nour hospital between 2005 to 2010 and diagnosed with schizophrenia in the first episode gathered. The implemented treatments compared with the American Psychiatric Association guideline for treatment of schizophrenia. Findings: Of total 113 patients with mean age of 28.91±8.79, 38 patients (33.6 percent) have been taken the adequate first line medications based on the APA guideline. In the all stages of the treatment, 45.24 percent of the patients have been taken medications with adherence to the guideline. Types of the drugs and duration of treatment in each stage were adhered to the guideline in 79.6 percent and 87.74 percent of the patients respectively. Conclusions: Adherence to the approved guideline was not acceptable. The most important finding was selection of the type of drug in the first stage, which was not compatible with the guideline. The high rate of polypharmacy was suggested the second fault of the treatment in this population.
Full-Text [PDF 249 kb]   (871 Downloads)    
Type of Study: Research | Subject: General
Received: 2020/02/8 | Published: 2014/02/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.